Combination of Thrombolysis and Glycoprotein IIb/IIIa Inhibition in Chronic Peripheral Thrombosis: A Case Report
Journal Title: International Journal of Radiology and Radiation Oncology - Year 2017, Vol 3, Issue 1
Abstract
Currently, many interventionalists employ either tissue plasminogen activator (alteplase, Genentech, San Francisco, CA), or recombinant plasminogen activator (reteplase, Chiesi USA, Inc., Cary, NC), for peripheral thrombolysis. Further, combination therapy utilizing a thrombolytic agent and a glycoprotein IIb/IIIa receptor antagonist has been proposed as a way to overcome the limitations of thrombolytic therapy alone by reducing the duration of infusion, preventing rethrombosis, and improving the efficacy of thrombolysis. The following report discusses a patient with stenoses in the distal right posterior tibial artery. The patient underwent percutaneous transluminal angioplasty along with tissue plasminogen activator infusion therapy. Initially, the tissue plasminogen activator infusion reduced pain. However, an embolic occlusion to the distal right lateral plantar artery led to recurrence of pain. Due to failure of thrombolytic monotherapy using tissue plasminogen activator, a combined treatment of eptifibatide (Integrilin, Cor Therapeutics and Schering-Plough) and tissue plasminogen activator infused intra-arterially was initiated. In this report, the successful clinical use of combination therapy has been demonstrated after failed intra-arterial tissue plasminogen activator infusion monotherapy. The use of purely intra-pedal intra-arterial eptifibatide is novel and should be studied in randomized trials to establish efficacy. Furthermore, we have shown that failure of monotherapy to treat occlusions can be recovered through the use of combination therapy.
Authors and Affiliations
Syed Mubin I, Gallagher Ryan, Hussain Zeshan, Shaikh Azim, Cain Philip J, Morar Kamal, Guehl Allen, Erdelyi Ronald
Keywords
Related Articles
- EP ID EP541303
- DOI 10.17352/ijrro.000020
- Views 74
- Downloads 0
Three Simple Software Extensions for Automatic Presentation of Radiation Induced Toxicity, Sequelae and Treatment Outcomes, for Increasing Safety in Daily Therapeutic Routine, and for Enhancing Patient Comfort
Background: Simple software extensions to already existing software-infrastructure can monitor treatment results, increase patient safety and enhance patient comfort in a very cost-effective way. This is of particular in...
Cardiac Computed Tomography Coronary Angiography Post Non-diagnostic or Equivocal Myocardial Perfusion SPECT
Background: Myocardial perfusion single- photon emission computed tomography (MP-SPECT) plays a key role in the management of patients with known or suspected coronary artery disease (CAD). However, Infrequently, MP-SPEC...
A comparative evaluation of two head and neck immobilization devices using verification film for head and neck cancer patients receiving radiation therapy at Ocean Road Cancer Institute (ORCI) aero-digestive tract
Background: Accurate and reproducible patient positioning is fundamental to the success of fractionated radiotherapy. To achieve accurate daily treatment delivery, various immobilization devices are used in radiotherapy...
Volumetric Modulated Arc Therapy versus Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer: A Systematic Literature Review
Aim: provide evidence concerning advantages of volumetric modulated arc therapy over intensity modulated radiation therapy. Background: external beam radiation therapy is a major treatment modality of prostate cancer; es...
Acoustic Radiation Force Impulse Imaging in the Differential Diagnosis of an Ectopic Intrathyroidal Thymus
Ectopic intrathyroidal thymus is caused by a hesitate in the migration of thymus during embryogenesis and is a rare cause of a nodular intrathyroidal lesion. Nodular thyroid lesions raise the suspicion of malignancy in t...